Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(43%)

Phase Distribution

Ph phase_3
1
14%
Ph phase_4
4
57%
Ph not_applicable
2
29%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Terminated(3)
Other(4)

Detailed Status

unknown4
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (14.3%)
Phase 44 (57.1%)
N/A2 (28.6%)

Trials by Status

unknown457%
terminated343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7